arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Embecta Corp.

EMBC
$4.41 ▲ +0.89 (+25.14%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
24 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
63
Health
Fair
Bullish
auto_awesome

Analytical Summary

Embecta Corp. shows strong fundamentals with top-quartile Debt to Equity and Operating Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $261.5M
Dividend Yield 3.40%
Revenue Growth -14.4%
Op. Margin 15.8%
ROIC -2.2%
FCF / Share $0.52
Trailing P/E
Price / Book
FCF Yield 11.7%
Debt / Equity -2.10
info Valuation on last close. End-of-day price, Aug 7, 2026.

24-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$221.80M
↓ -14.4%
Net Income Profit after all expenses
$-4.10M
↓ -109.3%
Operating Margin Operating profit as % of sales
15.8%
↓ -50.5% 78th
FCF / Share Free cash flow per share
$0.52
↑ +82.8%
Long-Term Debt Long-term obligations
$1.32B
↓ -2.7%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Operating Margin (%)Operating Margin (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
72
Returns
31
Financial Health
81
Cash Quality
85

Dividend History

Dividend / share · sourced from SEC filings
$0.60 Latest / share
+0.0% YoY
+58.7% 4-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 24 quarters